Topical NSAIDs for acute pain: A meta-analysis

BMC Family Practice

Volumn 5, Issue , 2004, Pages

  Mason, Lorna ^a   Moore, R Andrew ^a   Edwards, Jayne E ^a   Derry, Sheena ^a   McQuay, Henry J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FELBINAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO;

ANALGESIC ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; META ANALYSIS; PAIN; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TOPICAL TREATMENT; ACUTE DISEASE; ADULT; PAIN MEASUREMENT; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; HUMANS; KETOPROFEN; PAIN; PAIN MEASUREMENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 2642584185     PISSN: 14712296     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2296-5-10     Document Type: Review

References (62)

1. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ: Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998, 316:333-338.
2. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276:637-639.
3. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998, 352:609-613.
4. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ: Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998, 78:209-216.
5. Li Wan Po A:PJ Practice Checklist: Topical Analgesics. The Pharmaceutical Journal, December 1996.
6. British National Formulary No 45. London: British Medical Association, Royal Pharmaceutical Society; 2003.
7. Martindale: the extra pharmacopoeia. 32nd edition. Edited by Reynolds JEF. London: Royal Pharmaceutical Society; 1999.
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1-12.
9. Smith LA, Oldman AD, McQuay HJ, Moore RA: Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain 2000, 86:119-132.
10. Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452-454.
11. Morris JA, Gardner MJ:Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In Statistics with confidence - confidence intervals and statistical guidelines. Edited by Gardner MJ, Altman DG. London: British Medical Journal; 1995:50-63.
12. L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987, 107:224-233.
13. Gavaghan DJ, Moore RA, McQuay HJ: An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain 2000, 85:415-424.
14. Higgins J, Thompson S, Deeks J, Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7:51-61.
15. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ: Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997, 315:635-640.
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999, 354:1896-1900.
17. Predel:Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Supplied by Novartis (unpublished).
18. Airaksinen O, Venäläinen J, Pietiläinen T: Ketoprofen 2. 5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol 1993, 31:561-563.
19. Auclair J, Georges M, Grapton X, Gryp L, D'Hooghe M, Meisser RG, Noto R, Schmidtmayer B: A double-blind controlled multi-center study of percutaneous niflumic acid gel and placebo in the treatment of achilles heel tendinitis. Curr Ther Res 1989, 46:782-788.
20. Baracchi G, Messina Denaro S, Piscini S: [Experience of the topical use of isobutylfenylproprionic acid (Ibuprofen) in traumatic inflammation. A double-blind comparison with placebo]. Gazz Med Ital 1982, 141:691-694.
21. Billigman PW: Therapie von Sprunggelenks-distosionen mit ibuprofen-mikrogel. Therapiewoche 1996, 21:1187-1192.
22. Campbell J, Dunn T: Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accid Emerg Med 1994, 11:178-182.
23. Dreiser RL: Clinical trial of efficacy and tolerability of topical ibuprofen in the treatment of tendinitis. Le Journal International De Médecine 1988, 119:15-31.
24. Dreiser RL: Clinical trial - Fatsum gel FG-6. Supplied by Menarini (unpublished) 1989.
25. Dreiser RE, Charlot J, Lopez A, Ditisheim A: Clinical evaluation of niflumic acid gel in the treatment of uncomplicated ankle sprains. Curr Med Res Opin 1990, 12:93-99.
26. ™): Clinical evaluation in the treatment of acute ankle sprains. Eur J Rheumatol Inflamm 1994, 14:9-13.
27. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E: Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage 2000, 19:287-294.
28. Julien D: Clinical trial - Fastum gel FG-8. Supplied by Menarini (unpublished) 1989.
29. Kockelbergh M, Verspeelt P, Caloine R, Dermaux F: [Local anti inflammatory treatment with a ketoprofen gel: current clinical findings]. J Belg Med Phys Rehabil 1985, 8:205-213.
30. Machen J, Whitefield M: Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double blind placebo controlled study. Int J Clin Pharmacol 2002, 56:102-106.
31. McLatchie GR, McDonald M, Lawrence GF, Rogmans D, Lisai P, Hibberd M: Soft tissue trauma: a randomised controlled trial of the topical application of felbinac, a new NSAID. Br J Clin Pract 1989, 43:277-280.
32. Morris WD, Scott HV, Peters WA, Ketelbey JW: Felbinac topical gel for acute soft tissue sports injuries. N Z J Sports Med 1991, 19:45-47.
33. Noret A, Roty V, Allington N, Hauters P, Zuinen C, Poels R: Ketoprofen gel as topical treatment for sport injuries. Acta Ther 1987, 13:367-378.
34. Parrini M, Cabitza P, Arrigo A, Vanasia M: [Efficacy and tolerability of ketoprofen lysine salt foam for topical use in the treatment of traumatic pathologies of the locomotor apparatus]. Clin Ter 1992, 141:199-204.
35. Ramesh N, Steuber U: Dolgit® cream in accident- and sports-related injuries in medical practice. Results of a double blind study. Therapiewoche 1983, 33:4563-4570.
36. Russell AL: Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind study comparing efficacy and safety. Clin Invest Med 1991, 14:35-43.
37. Sanguinetti C: Trattemento con BPAA gel dei traumi dei tessuti moli. Clin Ter 1989, 130:255-258.
38. Sinniger M, Blanchard P: Controlled clinical trial with Fentiazac cream in sport microtraumatology. J Int Med Res 1981, 9:300-302.
39. Thorling J, Linden B, Berg R, Sandahl A: A double blind comparison of naproxen gel and placebo in the treatment of soft tissue injuries. Curr Med Res Opin 1990, 12:242-248.
40. Vecchiet L, Colozzi A: Effects of meclofenamic acid in the treatment of lesions deriving from minor traumatology. Clin J Pain 1991, 7 Suppl 1:S54-S59.
41. Battista Curioni G, Domenica FD, Daolio P, Spignoli G: Valutazione dell'efficacia terapeutica di ibudros gel in traumatologia. Clin Eur 1985, 24:456-460.
42. Governali E, Casalini D: Ricerda clinica controllata tra ketoprofene gel 5% e ketoprofene crema 1% in pazienti con postumi di lesioni traumatiche. Riabilitazione 1995, 28:61-69.
43. Gualdi A, Bonollo L, Martini A, Forgione A: Antinflammatori no steroidi per uso topico in traumatologia: studio clinico con flunoxaprofene e chetoprofene. Riforma Med 1987, 102:401-404.
44. Hosie GAC: The topical NSAID, felbinac, versus oral ibuprofen: a comparison of efficacy in the treatment of acute lower back injury. Br J Clin Res 1993; 4:5-17.
45. Picchio AA, Volta S, Longoni A: Studio clinico controllato sull'impiego dell'ibuprofen per uso topico in traumatologica sportiva. Med Sport 1981, 34:403-406.
46. Sugioka Y: Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non-traumatic diseases of tendon or muscle. Jap Pharmacol Ther 1984, 12:139-153.
47. Tonutti A: [The use of ketoprofen gel 5% (orudis gel) in traumatology: controlled double-blind study vs etofenamate]. Ort Traum Oggi 1994, 14:119-125.
48. Whitefield M, O'Kane CJA, Anderson S: Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomised, double blind study. J Clin Pharm Ther 2002, 27:409-417.
49. Åkermark C, Forsskåhl B: Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. Int J Sports Med 1990, 11:393-396.
50. Aoki T et al. Comparative study of piroxicam gel with indomethacin gel and piroxicam placebo gel in the treatment of pain from orthopedic trauma. Jap Pharmacol Ther 1984, 12:101-117.
51. Diebschlag W, Nocker W, Bullingham R: A double-blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. J Clin Pharmacol 1990, 30:82-89.
52. Fujimaki E et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double-blind, multicenter study. Jap Pharmacol Ther 1985, 12:119-137.
53. Terrin N, Schmid CH, Lau J, Olkin I: Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003, 22:2113-2126
54. MacLean CH, Morton SC, Ofman JJ, Roth EA, Shekelle PG: How useful are unpublished data from the Food and Drug Administration in meta-analysis? J Clin Epidemiol 2003, 56: 44-51.
55. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J: How important are comprehensive literature searches and the assessment of trial quality in systematic reviews. Empirical study. Health Technol Assess 2003, 7:1-76.
56. Burdett S, Stewart LA, Tierney JF: Publication bias and meta-analyses: a practical example. Int J Technol Assess Health Care 2003, 19:129-134.
57. Kalso E, Moore RA. Five easy pieces on evidence-based medicine (2). Eur J Pain 2000, 4:321-324.
58. Marjoribanks J, Proctor M, Farquhar C: Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003, 4:CD001751.
59. Towheed T, Shea B, Wells G, Hochberg M: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev 2000, 2:CD000517.
60. Watson MC, Brookes ST, Kirwan JR, Faulkner A: Non-aspirin, non-steroidal anti-inflammatory drugs (NSAIDS) for osteoarthritis of the knee. Cochrane Database Syst Rev 2000, 2:CD000142.
61. Evans JM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, MacDonald TM: Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995, 311:22-26.
62. Evans JM, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, McDevitt DG, MacDonald TM: Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995, 88:551-557.